These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 24338950

  • 41. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH.
    J Biol Chem; 2008 Oct 10; 283(41):27707-27716. PubMed ID: 18687691
    [Abstract] [Full Text] [Related]

  • 42. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
    Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D.
    Oncotarget; 2015 Oct 06; 6(30):29947-62. PubMed ID: 26359358
    [Abstract] [Full Text] [Related]

  • 43. Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation.
    Liu F, Zhang Y, Xia X, Han J, Cao L.
    J Obstet Gynaecol Res; 2024 Jun 06; 50(6):1010-1019. PubMed ID: 38576101
    [Abstract] [Full Text] [Related]

  • 44. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM.
    J Biol Chem; 2012 Jul 13; 287(29):24832-43. PubMed ID: 22654108
    [Abstract] [Full Text] [Related]

  • 45. Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-κB and HSP90 in castration resistant prostate cancer.
    Kim Y, Park SE, Moon JW, Kim BM, Kim HG, Jeong IG, Yoo S, Ahn JB, You D, Pak JH, Kim S, Hwang JJ, Kim CS.
    Prostate; 2017 Jul 13; 77(10):1128-1136. PubMed ID: 28556958
    [Abstract] [Full Text] [Related]

  • 46. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
    Zhu W, Zhang JS, Young CY.
    Carcinogenesis; 2001 Sep 13; 22(9):1399-403. PubMed ID: 11532861
    [Abstract] [Full Text] [Related]

  • 47. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K, Liu H, Kim S, Guo M, Navarro V, Bander NH.
    Prostate; 2009 Oct 01; 69(14):1579-85. PubMed ID: 19575420
    [Abstract] [Full Text] [Related]

  • 48. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B, Alapinar C, Varisli L, Erbaykent-Tepedelen B, Hamid SM, Gonen-Korkmaz C, Korkmaz KS.
    Mol Carcinog; 2014 Feb 01; 53(2):85-97. PubMed ID: 22911881
    [Abstract] [Full Text] [Related]

  • 49. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.
    Zhang Y, Kim KH, Zhang W, Guo Y, Kim SH, Lü J.
    Int J Cancer; 2012 Jan 01; 130(1):200-12. PubMed ID: 21328348
    [Abstract] [Full Text] [Related]

  • 50. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
    Chen M, Feuerstein MA, Levina E, Baghel PS, Carkner RD, Tanner MJ, Shtutman M, Vacherot F, Terry S, de la Taille A, Buttyan R.
    Mol Cancer; 2010 Apr 26; 9():89. PubMed ID: 20420697
    [Abstract] [Full Text] [Related]

  • 51. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH, Lee HJ, Jeong SJ, Lü J, Kim SH.
    Phytother Res; 2012 May 26; 26(5):669-74. PubMed ID: 21997969
    [Abstract] [Full Text] [Related]

  • 52. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N, Jiang L, Deng P, Xu H, Chen F, Liu J, Li J, Liao G, Zeng X, Lin Y, Feng M, Li L, Chen Q.
    J Oral Pathol Med; 2017 Mar 26; 46(3):201-207. PubMed ID: 27465776
    [Abstract] [Full Text] [Related]

  • 53. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS, Krishnan AV, Swami S, Feldman D.
    Mol Cancer Ther; 2006 Jun 26; 5(6):1539-49. PubMed ID: 16818513
    [Abstract] [Full Text] [Related]

  • 54. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
    Balan M, Chakraborty S, Flynn E, Zurakowski D, Pal S.
    Sci Rep; 2017 Jul 19; 7(1):5900. PubMed ID: 28724911
    [Abstract] [Full Text] [Related]

  • 55. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
    Ikezoe T, Chen SS, Yang Y, Heber D, Taguchi H, Koeffler HP.
    Int J Oncol; 2003 Nov 19; 23(5):1461-70. PubMed ID: 14532991
    [Abstract] [Full Text] [Related]

  • 56. ING3 promotes prostate cancer growth by activating the androgen receptor.
    Nabbi A, McClurg UL, Thalappilly S, Almami A, Mobahat M, Bismar TA, Binda O, Riabowol KT.
    BMC Med; 2017 May 16; 15(1):103. PubMed ID: 28511652
    [Abstract] [Full Text] [Related]

  • 57. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.
    Liu SH, Shen CC, Yi YC, Tsai JJ, Wang CC, Chueh JT, Lin KL, Lee TC, Pan HC, Sheu ML.
    Br J Pharmacol; 2010 Aug 16; 160(8):1963-72. PubMed ID: 20649594
    [Abstract] [Full Text] [Related]

  • 58. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
    Zhou B, Li H, Xing C, Ye H, Feng J, Wu J, Lu Z, Fang J, Gao S.
    Biochem Pharmacol; 2017 Mar 15; 128():12-25. PubMed ID: 28043811
    [Abstract] [Full Text] [Related]

  • 59. The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells.
    Fajardo AM, MacKenzie DA, Ji M, Deck LM, Vander Jagt DL, Thompson TA, Bisoffi M.
    Prostate; 2012 May 01; 72(6):612-25. PubMed ID: 21796654
    [Abstract] [Full Text] [Related]

  • 60. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.
    Ferreira LB, Palumbo A, de Mello KD, Sternberg C, Caetano MS, de Oliveira FL, Neves AF, Nasciutti LE, Goulart LR, Gimba ER.
    BMC Cancer; 2012 Nov 06; 12():507. PubMed ID: 23130941
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.